
Routine Blood Pressure Readings May Flag Early Dementia Risk, Studies Show
Measures of blood vessel health derived from routine blood pressure readings could help identify adults at heightened risk for dementia, according to new research unveiled

Measures of blood vessel health derived from routine blood pressure readings could help identify adults at heightened risk for dementia, according to new research unveiled

Ez-PAVE trial: aiming for LDL-C below 55 mg/dL rather than 70 mg/dL reduces major cardiovascular events by 33% in patients with atherosclerotic cardiovascular disease, providing

CHAMPION-AF trial: Left atrial appendage closure proves non-inferior to NOACs for stroke, cardiovascular death and embolism at three years, while cutting non-procedural bleeding rates nearly

VESALIUS-CV subanalysis: evolocumab reduces major adverse cardiac events by 31% in patients with diabetes but no known atherosclerosis, potentially redefining the role of PCSK9 inhibitors

Phase 2 trial of tonlamarsen in resistant hypertension: the drug’s unexpectedly prolonged action confounds interpretation of results, raising new questions about how much angiotensinogen suppression

STEMI-DTU trial: Delayed reperfusion with LV unloading shows no significant benefit over immediate PCI, though a potentially offsetting protective effect of the pump warrants further

In a groundbreaking development for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), the Phase 3 SEQUOIA-HCM trial has demonstrated that aficamten, an investigational oral selective

In a groundbreaking analysis of the STEPHFpEF programme, researchers have discovered that semaglutide, a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA), not only improves heart failure-related

In a thought-provoking presentation, Dr. Milton Packer, a renowned expert in the field of cardiology, shed light on the groundbreaking findings from recent SGLT2 inhibitor

Professor Mark Petrie from the University of Glasgow and Glasgow Royal Infirmary presented an overview of the future directions and novel treatment strategies for heart